Evidence map›Paper›PMID 19777373›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2009

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis.

M J Harrison, L M Davies, N J Bansback, M J McCoy, S M M Verstappen, K Watson, D P M Symmons, British Society for Rheumatology Biologics Register Control Centre Consortium

Abstract readComparative Study
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Assessing the validity and responsiveness of a generic preference quality of life measure in the context of posttraumatic stress disorder.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).The European journal of health economics : HEPAC : health economics in prevention and care · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approach.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2013
    Article
  19. Health-related quality of life changes associated with buprenorphine treatment for opioid dependence.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

M J HarrisonARC Epidemiology Unit, Stopford Building, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK. mark.harrison@manchester.ac.uk
L M Davies
N J Bansback
M J McCoy
S M M Verstappen
K Watson
D P M Symmons
British Society for Rheumatology Biologics Register Control Centre Consortium

Funding

Arthritis Research UK 17552
6 · The paper itself

Abstract

purposeComparative evidence regarding the responsiveness of the EQ-5D and SF-6D in arthritis patients is conflicting and insufficient across the range of disease severity. We examined the comparative responsiveness of the EQ-5D and SF-6D in cohorts of patients with early inflammatory disease through to severe rheumatoid arthritis (RA).

methodsResponsiveness was tested using the effect size (ES) and standardised response mean (SRM). Correlation of change in EQ-5D and SF-6D with disease specific measures was tested using Pearson correlations and the Steiger's Z test. Treatment response and self-reported change were used as anchors of important change.

resultsThe EQ-5D was more responsive to deterioration (ES ratio (EQ-5D/SF-6D): 1.6-3.0) and the SF-6D more responsive to improvement (ES ratio (SF-6D/EQ-5D): 1.1-1.8) in health. The SF-6D did not respond well to deterioration in patients with established severe RA (ES and SRM 0.08). The EQ-5D provided larger absolute mean change estimates but with greater variance compared to the SF-6D.

conclusionsThe comparative responsiveness of the EQ-5D and SF-6D differs according to the direction of change. The level of mean change of the EQ-5D relative to the SF-6D has implications for cost-effectiveness analysis. Use of the SF-6D in patients with severe progressive disease may be inappropriate.

Indexed as

Quality of LifeSurveys and QuestionnairesAdultAgedArthritis, RheumatoidFemaleHumansMaleMiddle AgedOutcome Assessment, Health CareReproducibility of Results

Identifiers

PMID19777373
PMCPMC2761817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.